Chemistry:IMM-101
From HandWiki
Short description: Experimental medication
| Clinical data | |
|---|---|
| Other names | Mycobacterium obuense (heat-killed) |
| Identifiers | |
| UNII | |
IMM-101 is an immunomodulatory drug that is being studied to see if it is useful in chemotherapy.[1] It consists of heat-killed Mycobacterium obuense bacteria. It may have relatively few side effects compared to other drugs.[2][3]
References
- ↑ "Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer". British Journal of Cancer 115 (7): 789–796. September 2016. doi:10.1038/bjc.2016.271. PMID 27599039.
- ↑ "New drug 'wakes up' immune system to fight one of deadliest cancers". The Guardian. 6 September 2016. https://www.theguardian.com/science/2016/sep/06/new-drug-wakes-up-immune-system-to-fight-one-of-deadliest-cancers.
- ↑ "A trial looking at a new type of immunotherapy for cancer of the pancreas that can't be removed with surgery". Cancer Research UK. http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-new-type-immunotherapy-cancer-pancreas-cannot-be-removed-with-surgery.
 |  |
